The Valley Desk

Clinical trial reportLung cancer (Amsterdam, Netherlands)Published

Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Lung cancer (Amsterdam, Netherlands)
Published
Subject terms
Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Piperazines; Phthalazines; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Small Cell Lung Carcinoma; B7-H1 Antigen; Immunotherapy; small cell lung cancer; Olaparib
PubMed ID
37146473
Added to directory
Source checked

Report a correction or request removal